Share this page!

Kai Kupferschmidt Profile picture
Twitter logo
19 Feb, 4 tweets, 2 min read
Wir sind wieder da! :)
In der ersten Folge @pandemiapodcast fürs neue Jahr geht es noch einmal um Gelbfieber. Dieses Mal: Impfstoff ist knapp und was passiert, wenn das Virus nach Asien gelangt?
Die letzten zwei Monate waren für mich vor allem wegen der Berichterstattung über #b117 und andere Varianten von #SARSCoV2 unglaublich intensiv und anstrengend. Aber ich habe das Podcasten und meine Kolleginnen und euch die Hörer vermisst.
Für die nächsten Wochen und Monate haben wir schon eine Menge spannende Themen geplant. Aber für Vorschläge, Fragen, Kritik etc. sind wir immer dankbar.
Wir haben die Pause auch genutzt, um uns ein wenig nachhaltiger aufzustellen. Ihr könnt uns nach wie vor indirekt unterstützen, über @riffreporter oder @4000hertz.
Aber ab sofort könnt ihr uns hier auch direkt unterstützen und noch mehr Pandemia hören: steadyhq.com/en/pandemia/ab…

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Kai Kupferschmidt

Kai Kupferschmidt Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kakape

Kai Kupferschmidt Profile picture
17 Feb
I’m really struggling with this idea of a race to vaccinate everyone HERE now. Yes, we all want vaccine asap. But while we are discussing how soon we can immunize everyone in Germany or the US, health workers are dying in countries with zero doses so far.

sciencemag.org/news/2021/02/u…
In Zimbabwe, one of the top doctors and HIV/AIDS researchers, James Hakim, died in late January.
As his colleague and former student Leolin Katsidzira told me: "people like James are people who keep the system going”.
Here is one of many tributes: kcl.ac.uk/news/tribute-t…
Hakim’s death came within hours of the death of David Katzenstein, another important HIV/AIDS researcher and voice for global health, in the same hospital in Harare.
Here is a good piece on him and his work:
med.stanford.edu/news/all-news/…
Read 9 tweets
Kai Kupferschmidt Profile picture
15 Feb
"The number of reported cases of #COVID19 globally has now declined for the fifth consecutive week”, says @drtedros at @WHO presser.
"The number of weekly reported cases has fallen by almost half” in 5 weeks, from more than 5 million to 2.6 million cases."
@DrTedros @WHO "What matters now is how we respond to this trend”, says @DrTedros.
"The fire is not out, but we have reduced its size. If we stop fighting it on any front, it will come roaring back."
@DrTedros @WHO Good news:
"Today, @WHO gave emergency use listing to two versions of the Oxford-AstraZeneca #COVID19 vaccine, giving the green light for these vaccines to be rolled out globally through COVAX”, says @drtedros.
Read 24 tweets
Kai Kupferschmidt Profile picture
12 Feb
“I wish to confirm that all hypotheses remain open and require further analysis and studies”, says @drtedros about origin of #covid19 at @WHO presser. Calls the origins mission "a very important scientific exercise in very difficult circumstances”.
@DrTedros @WHO "The expert team is working on a summary report which we hope will be published next week”, says @DrTedros.
“The full final report will be published in the coming weeks.”
@DrTedros @WHO “The number of reported cases of #COVID19 globally has declined for the 4th week in a row and the number of deaths also fell for the 2nd consecutive week” says @DrTedros. "This decline appears to be due to countries implementing public health measure more stringently."
Read 13 tweets
Kai Kupferschmidt Profile picture
11 Feb
Good news (again) from the UK’s impressive Recovery trial:

Tocilizumab reduced deaths from #COVID19 by about 4% and that was on top of dexamethasone.
It means that giving 25 people this drug on top of the standard of care will lead to one saved life.
Tocilizumab also reduced the need for a mechanical ventilator and shortened the hospital stay.

All of this is from press release for now: recoverytrial.net/news/tocilizum…
Manuscript is working its way through medrxiv right now.
Tocilizumab is an anti-inflammatory drug, an antibody that targets the IL-6 receptor, dampening the immune system. It is used to treat rheumatoid arthritis.

It is also about 100x as expensive as dexamethasone, so it will probably increase the global inequities of this pandemic.
Read 4 tweets
Kai Kupferschmidt Profile picture
9 Feb
Press conference on what @WHO-convened mission to investigate the origins of #SARSCoV2 found on their China trip is about to start in Wuhan.
(Was originally supposed to start an hour ago before being pushed back)
@WHO It finally started this minute.
@WHO After a lengthy introduction of the mission and its terms of reference, Liang Wannian, who leads the Chinese team of the joint mission, says he will now begin to talk about the key findings, starting with molecular epidemiology.
Read 29 tweets
Kai Kupferschmidt Profile picture
8 Feb
“It seems increasingly clear that manufacturers will have to adjust to the evolution of the virus, taking into account the latest variants for future shots, including boosters”, says @DrTedros at @WHO presser. “We have to be ready to adapt vaccines so they remain effective."
@DrTedros @WHO "These developments highlight why it's so important to scale up manufacturing and rollout vaccines as quickly as possible and as widely as possible to protect people before they're exposed to new variants”, says @drtedros.
@DrTedros @WHO “We need to do everything we can to reduce circulation of the virus with proven public health measures”, says @DrTedros. "Several countries are succeeding in suppressing transmission including those where new variants are circulating."
Read 30 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

Like this author's thread?

Get emails when @kakape has new unrolls!

Check out other threads from @kakape!

Read all threads by @kakape